Plato Investment Management Ltd trimmed its holdings in The Sherwin-Williams Company (NYSE:SHW – Free Report) by 4.1% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 13,503 shares of the specialty chemicals company’s stock after selling 573 shares during the quarter. Plato Investment Management Ltd’s holdings in Sherwin-Williams were worth $5,148,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds also recently bought and sold shares of SHW. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund boosted its holdings in Sherwin-Williams by 61.6% during the third quarter. United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund now owns 65,039 shares of the specialty chemicals company’s stock worth $24,823,000 after buying an additional 24,794 shares in the last quarter. Oppenheimer & Co. Inc. raised its position in shares of Sherwin-Williams by 0.9% during the third quarter. Oppenheimer & Co. Inc. now owns 8,629 shares of the specialty chemicals company’s stock worth $3,293,000 after purchasing an additional 75 shares during the period. Oppenheimer Asset Management Inc. boosted its position in shares of Sherwin-Williams by 2.3% in the 3rd quarter. Oppenheimer Asset Management Inc. now owns 32,689 shares of the specialty chemicals company’s stock valued at $12,476,000 after purchasing an additional 725 shares during the period. Angeles Investment Advisors LLC purchased a new stake in Sherwin-Williams during the third quarter valued at about $208,000. Finally, Simmons Bank boosted its holdings in shares of Sherwin-Williams by 4.8% in the third quarter. Simmons Bank now owns 737 shares of the specialty chemicals company’s stock worth $281,000 after buying an additional 34 shares during the period. 77.67% of the stock is owned by institutional investors and hedge funds.
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on the stock. StockNews.com downgraded shares of Sherwin-Williams from a “buy” rating to a “hold” rating in a research report on Wednesday, October 30th. KeyCorp restated a “sector weight” rating on shares of Sherwin-Williams in a report on Monday, October 7th. Evercore ISI lifted their price target on Sherwin-Williams from $400.00 to $420.00 and gave the company an “outperform” rating in a report on Thursday, November 7th. Barclays increased their price objective on Sherwin-Williams from $355.00 to $370.00 and gave the stock an “equal weight” rating in a research note on Wednesday, October 23rd. Finally, UBS Group reaffirmed an “underperform” rating on shares of Sherwin-Williams in a research note on Friday, October 18th. One research analyst has rated the stock with a sell rating, seven have given a hold rating, twelve have issued a buy rating and one has given a strong buy rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $396.47.
Insiders Place Their Bets
In other news, CFO Allen J. Mistysyn sold 14,520 shares of Sherwin-Williams stock in a transaction that occurred on Friday, August 30th. The shares were sold at an average price of $366.83, for a total value of $5,326,371.60. Following the transaction, the chief financial officer now owns 63,520 shares of the company’s stock, valued at $23,301,041.60. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.60% of the company’s stock.
Sherwin-Williams Stock Performance
Shares of SHW opened at $387.29 on Thursday. The company has a quick ratio of 0.51, a current ratio of 0.83 and a debt-to-equity ratio of 1.97. The Sherwin-Williams Company has a 12 month low of $258.52 and a 12 month high of $392.57. The company’s fifty day moving average is $375.00 and its 200-day moving average is $340.53. The firm has a market cap of $97.54 billion, a price-to-earnings ratio of 38.57, a price-to-earnings-growth ratio of 3.09 and a beta of 1.17.
Sherwin-Williams (NYSE:SHW – Get Free Report) last posted its earnings results on Tuesday, October 22nd. The specialty chemicals company reported $3.37 earnings per share for the quarter, missing the consensus estimate of $3.56 by ($0.19). Sherwin-Williams had a net margin of 11.09% and a return on equity of 74.45%. The company had revenue of $6.16 billion for the quarter, compared to the consensus estimate of $6.20 billion. During the same quarter last year, the business earned $3.20 earnings per share. Sherwin-Williams’s quarterly revenue was up .7% on a year-over-year basis. Equities analysts expect that The Sherwin-Williams Company will post 11.32 EPS for the current fiscal year.
Sherwin-Williams Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Friday, December 6th. Investors of record on Friday, November 15th will be issued a $0.715 dividend. The ex-dividend date is Friday, November 15th. This represents a $2.86 annualized dividend and a yield of 0.74%. Sherwin-Williams’s dividend payout ratio (DPR) is currently 28.49%.
Sherwin-Williams Company Profile
The Sherwin-Williams Company engages in the development, manufacture, distribution, and sale of paints, coating, and related products to professional, industrial, commercial, and retail customers. It operates through three segments: Paint Stores Group, Consumer Brands Group, and Performance Coatings Group.
Featured Articles
- Five stocks we like better than Sherwin-Williams
- How to Capture the Benefits of Dividend Increases
- Can United States Cellular Ride Higher on Its Spectrum Strategy?
- 3 Best Fintech Stocks for a Portfolio Boost
- HubSpot’s Growth in CRM: Can It Compete With Salesforce?
- Are Penny Stocks a Good Fit for Your Portfolio?
- Neurogene Stock Plummets 44%: Is All Hope Lost for This Biotech?”
Want to see what other hedge funds are holding SHW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Sherwin-Williams Company (NYSE:SHW – Free Report).
Receive News & Ratings for Sherwin-Williams Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sherwin-Williams and related companies with MarketBeat.com's FREE daily email newsletter.